Search Contract Opportunities

Isolator

ID: FDA-RFQ-24-121770 • Type: Synopsis Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

The U.S. Food and Drug Administration (FDA), New York Laboratory Medical Products (NYLMP) has a requirement for an Isolator.

All quotes are due, electronically via email to Nina.Montgomery@fda.hhs.gov no later than September 17, 2024 10:00 a.m. (EST)

Late submissions may not be evaluated.

Background
The U.S. Food and Drug Administration (FDA), New York Laboratory Medical Products (NYLMP) in the Office of Regulatory Science (ORS), Office of Medical Products and Specialty Lab Operations (OMPSLO), located at 158-15 Liberty Avenue, Jamaica, NY, 11433, is experiencing significant growth in the demand for sterility testing.

To maintain high standards of quality and meet accreditation requirements, there is a recognized need to enhance NYLMP’s infrastructure by incorporating isolators. This acquisition aims to alleviate current resource strains and enhance analytical capabilities in sterility analysis.

Work Details
The contract requires the provision of one isolator designed to support sterility analysis processes within NYLMP. The isolator must meet the following specifications:
- Modular rigid-wall with fast bio-decontamination solutions
- Full traceability compliant with FDA 21 CFR Part 11
- Upwards opening door with optional transfer hatch and main chamber
- Validated process control providing connectivity and traceability
- Safe access to the chamber and hatch
- (1) 4 glove Isoflex-UDAF 110V/UL Siemens PLC/Win 10 panel PC HMI in English
- Integrated H2O2 generator
- Bio decontamination hatch on LH side with internal basket and 2 shelves
- Openable glass window with inflatable gasket
- Sleeve extenders for biodecontamination with finger separators
- Hanging bars with hooks
- Removable drain on clamp for liquid filtrate
- Modular shelving with 4x4 baskets
- DPTE-XS 190 on base for waste, with false container
- Fully integrated glove leak tester with wifi plug, charging station, self-test features
- Millipore Symbio US pump with foot pedal, supply and integration
- MAS100-ISO NT active air sampler supply and integration
- Integrated low concentration H2O2 sensor for operator safety; high concentration H2O2 sensor for hatch/workstation; additional low concentration sensor for hatch/workstation; 316L on RH side wall for future DPTE=XS 190; H2O2 catalytic converter; documentation package in English; preparation/packing in wooden box for sea freight including disconnection of the hatch; GAMPS documentation package in English; capable of producing vaporized hydrogen peroxide for decontaminating work surfaces by a minimum of a 6 log reduction of spores. Comprehensive user manuals and training for at least four personnel using the isolators are also required.

Place of Performance
158-15 Liberty Avenue, Jamaica, NY, 11433

Overview

Response Deadline
Sept. 17, 2024, 10:00 a.m. EDT Past Due
Posted
Sept. 11, 2024, 8:58 a.m. EDT
Set Aside
None
Place of Performance
Jamaica, NY 11433 United States
Source

Current SBA Size Standard
1000 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Low
Est. Value Range
Experimental
$50,000 - $150,000 (AI estimate)
Signs of Shaping
The solicitation is open for 6 days, below average for the Food and Drug Administration.
On 9/11/24 Food and Drug Administration issued Synopsis Solicitation FDA-RFQ-24-121770 for Isolator due 9/17/24. The opportunity was issued full & open with NAICS 334516 and PSC 6640.
Primary Contact
Name
Nina Montgomery   Profile
Phone
(240) 402-8086

Documents

Posted documents for Synopsis Solicitation FDA-RFQ-24-121770

Opportunity Assistant


AI Analysis

AI Generate

Contract Awards

Prime contracts awarded through Synopsis Solicitation FDA-RFQ-24-121770

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation FDA-RFQ-24-121770

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation FDA-RFQ-24-121770

Experts for Isolator

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Oct. 2, 2024
Last Updated By
nina.montgomery@fda.hhs.gov
Archive Date
Oct. 2, 2024